Document Type


Publication Date



Nationally, incidence of new HIV infections has hovered around over 50,000 per year and men who have sex with men (MSM) carry the largest burden. In Vermont, 56% of individuals newly diagnosed are MSM, with 25% of diagnoses among youth ages 13-24 years old. Despite the proven efficacy and approval of daily Truvada (emtricitabine + tenofovir) as Pre-Exposure Prophylaxis (PrEP) against HIV infection, provider understanding and awareness of its use has remained extremely limited in Vermont with last estimates at just over 9 providers familiar with PrEP (excluding UVM Student Health, Planned Parenthood, and UVM Medical Center infectious disease department). Based on a UVM College of Medicine student public health project which identified provider training and education as the largest barrier to prescribing PrEP, this ongoing project aims to familiarize Vermont primary care providers with language and sexual history taking in MSM, emphasize accurate identification of higher risk times for HIV infection in an individual's lifetime, and encourage consideration for PrEP as a powerful element of a comprehensive sexual health program.


Please see the PrEP HANDOUT at the bottom of this page for "schedule" of labs for PrEP.

This is an update of a Family Medicine Clerkship Project: Ohkura, Michael, "Facilitating HIV Pre-Exposure Prophylaxis (PrEP) Familiarity Among Vermont Primary Care Providers" (2016). Family Medicine Block Clerkship, Student Projects. 193.

PrEP HANDOUT.pdf (461 kB)